What Toho Holdings does

Toho Holdings Co., Ltd. (TSE: 8129), headquartered in Setagaya-ku, Tokyo, is the holding company of the Kyoso Mirai Group, a vertically integrated Japanese healthcare distribution group operating across three core pillars: pharmaceutical wholesale, dispensing pharmacy, and pharmaceutical manufacturing. Through wholly-owned subsidiary Toho Pharmaceutical Co., Ltd., the group supplies ethical drugs, diagnostic reagents, medical devices, OTC products, and medical materials to hospitals, clinics, and dispensing pharmacies nationwide, complemented by customer support systems, in-hospital SPD logistics, and the Specialty Products Full-Line Service that links biotech venture investments through to last-mile patient delivery. Toho Pharmacy Group operates dispensing pharmacies delivering medication guidance, home healthcare, and OTC sales, while Kyoso Mirai Pharma manufactures generic drugs and offers contract manufacturing of ampule and vial formulations with full-line development, regulatory filing, and QC testing services.

The group's logistics backbone centers on the TBC (Toho Business Center) network — ISO 9001-certified facilities in Tokyo (TBC Dynabase), Saitama, Hanshin, Hiroshima, Kyushu, and Sapporo — with TBC Dynabase co-located in the Tokyo Metropolitan Government-designated Keihin Truck Terminal for disaster-response wide-area transport. The proprietary Salmu temperature-controlled transport system (Salmu TS: +4°C to +37°C; Salmu FZ: -25°C to +4°C) maintains continuous temperature records for over one month under GDP-compliant cold chain guidelines, enabling product returns and resales. The No-Check Shipping System achieves a stated 99.99999% (seven nines) shipping accuracy rate, eliminating receiving inspection at customer sites.

Revenue is generated primarily through transaction-based pharmaceutical wholesale to medical institutions, transaction fees from dispensing pharmacy operations, and one-time/license-style revenue from contract manufacturing and formulation design services. The company also earns professional services revenue from software sales to medical institutions, clinical trial facility support, and specialty pharmaceutical-related services. All operations are domestic (Japan only), with the company publicly listed on the Tokyo Stock Exchange and currently subject to ongoing governance tensions with activist shareholder 3D Investment Partners (~24% voting rights since July 2020), including a 2026 Glass Lewis recommendation to vote against the company's poison pill defense.

Name

Toho Holdings

Legal name

TOHO HOLDINGS CO.,LTD. (東邦ホールディングス株式会社)

Website

https://tohohd.co.jp

Company type

Public

Founded year

1948

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Toho Holdings is a Japanese pharmaceutical holding company operating an integrated wholesale, dispensing pharmacy, and generic manufacturing group serving hospitals, clinics, and pharmacies nationwide, supported by a GDP-compliant TBC logistics network and the proprietary Salmu temperature-controlled transport system.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution

NAICS

Pharmaceutical and Medicine Manufacturing (3254), General Warehousing and Storage (493110), Refrigerated Warehousing and Storage (493120)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Pharmaceutical Preparations (2834)

akta.pro primary industry

Pharmaceutical & Life Sciences Warehousing (GDP-Compliant) (TLAIACAD)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical distribution
• Dispensing pharmacy
• Generic pharmaceuticals
• Healthcare logistics

Headquarters

HQ city

Tokyo

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Infrastructure, Personnel, Technology or R&D

Revenue model

1. Pharmaceutical Wholesale: Core pharmaceutical distribution business supplying pharmaceuticals, diagnostic reagents, medical devices, OTC products to medical institutions including hospitals and clinics.
2. Dispensing Pharmacy: Operation of dispensing pharmacies providing medication dispensing, medication guidance, home healthcare, OTC sales, and coordination with other healthcare providers.
3. Pharmaceutical Manufacturing and Sales: Production and sales of generic pharmaceuticals, contract manufacturing of ampule/vial formulations, full-line services including formulation design, regulatory filing support, and quality control testing services.
4. Support Services: Software sales to medical institutions, clinical trial facility support, and specialty pharmaceutical-related services.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Toho Holdings is a holding company for the Kyoso Mirai Group operating three integrated healthcare businesses in Japan: pharmaceutical wholesale of ethical drugs, diagnostic reagents, medical devices, and OTC products to hospitals, clinics, and pharmacies; dispensing pharmacy operations providing medication dispensing, patient counseling, and home healthcare; and pharmaceutical manufacturing and sales of generic drugs and contract ampoule/vial production with full-line services. The group supports these operations with advanced logistics infrastructure including the TBC Dynamabase center and proprietary temperature-controlled transport systems.

Product overview

Toho Holdings operates as a pharmaceutical wholesale and healthcare group offering four core business segments: Pharmaceutical Wholesale (handling drugs, diagnostics, medical devices, and OTC products with customer support and logistics systems), Dispensing Pharmacy (providing dispensing, medication guidance, and home healthcare services), Pharmaceutical Manufacturing and Sales (producing generic drugs and offering contract manufacturing with full-line services), and Other businesses (information processing, clinical trial support, and specialty pharmaceutical services). The group operates advanced logistics infrastructure including TBC Dynabase and Haneda Packaging Center, supported by proprietary technology solutions like the Salum temperature-controlled transport system. The company positions itself as a total healthcare support partner serving medical institutions across Japan.

Differentiator

Problem solved

Functional benefit

Brands

• TBCダイナベース (TBC Dynabase): High-function logistics center operated by the Toho Group located within the Keihin Truck Terminal in Tokyo, designed for rapid and stable pharmaceutical supply even during large-scale disasters.
• サルム・ソリューション・システム (Saluum Solution System)
• 共創未来グループ (Kyoso Mirai Group)

Products and services

• Pharmaceutical Wholesale Business (医薬品卸売事業) Wholesale distribution of ethical drugs, diagnostic reagents, medical devices, OTC products, and medical materials to medical institutions (hospitals, clinics) supported by customer support systems and SPD (Supply, Processing and Delivery) services.
• Dispensing Pharmacy Business (調剤薬局事業) Operation of dispensing pharmacies providing medication dispensing, medication guidance, home healthcare, OTC sales, and coordination with other medical professionals and administrative bodies for community-based care.
• Pharmaceutical Manufacturing and Sales Business (医薬品製造販売事業) Manufacturing and sales of high-quality generic drugs, contract manufacturing of ampoule/vial formulations, and full-line services from formulation design to regulatory filing and quality control testing.
• TBC Dynabase (TBCダイナベース) High-functionality logistics center located within the Keihin Truck Terminal in Tokyo, designated by the Tokyo Metropolitan Government as a disaster response transportation hub for rapid pharmaceutical supply during large-scale disasters.
• Salum Solution System (サルム・ソリューション・システム) Temperature-controlled transport system using electronic cooling devices (Salum TS for +4°C to +37°C and Salum FZ for -25°C to +4°C) with continuous temperature recording for over one month, GDP-compliant, enabling product returns and resale.
• Haneda Packaging Center (羽田パッケージングセンター) Secondary packaging facility co-located within TBC Dynabase supporting specialty product full-line services for domestic and international bioventure companies and pharmaceutical manufacturers.
• Customer Support System (顧客支援システム) Systems and services supporting medical institution operations including efficiency improvements, startup support, and in-hospital logistics (SPD) to contribute to total healthcare support.
• Specialty Products Full-Line Service (スペシャリティ製品フルラインサービス) Comprehensive service from biotech venture investment through drug development support, secondary packaging, manufacturer logistics, wholesale distribution, to last-mile delivery to patient homes for bioventure and specialty pharmaceutical manufacturers.

Quantifiable outcome

• 99.99999% shipping accuracy rate (seven nines) enabling no-check delivery
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators5 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• McKesson Corporation: Global pharmaceutical distribution incumbent operating North America and European wholesale, specialty distribution, and biopharma services. Useful as a strategic benchmark for Toho's specialty pharma and biopharma services ambitions, particularly around cold-chain and biopharma distribution.
• Cardinal Health: U.S. pharmaceutical distributor with significant at-home solutions, specialty distribution (Cardinal Health Specialty Solutions), and global medical product distribution. Comparable to Toho at the strategic distribution level despite operating in different geographies.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical solutions company offering wholesale distribution, specialty distribution (including animal health and biopharma services), and consulting. Relevant comparison point for Toho's specialty pharmaceutical full-line service and biopharma distribution strategy.

Direct peers

• Alfresa Corporation: One of the major Japanese pharmaceutical wholesalers with integrated wholesale, dispensing pharmacy, and group-wide healthcare support services. Directly comparable to Toho in scale, business mix, and customer segment focus, with parallel investments in generic manufacturing.
• Medipal Holdings: Japan's largest pharmaceutical wholesaler, operating nationwide distribution alongside dispensing pharmacy and medical device businesses. Closest direct competitor to Toho in Japan, with overlapping health insurance pharmacy, SPD, and specialty pharma logistics capabilities following Medipal's integration of Suzuken.

Emerging players

• Nichi-Iko Pharmaceutical: Japan-focused generic pharmaceutical manufacturer with significant domestic generic share. Comparable to Toho's Kyoso Mirai Pharma subsidiary in the generic manufacturing and regulatory service space, offering a direct competitive benchmark for Toho's manufacturing arm.
• Sawai Group Holdings: Japanese generic pharmaceutical manufacturer with strong domestic and U.S. operations, including recent U.S. generics expansion through the Upsher-Smith acquisition. Comparable to Toho's Kyoso Mirai Pharma in generic manufacturing capabilities and ambitions.

Regional players

• EPS Holdings: Japan-based provider of CRO/site management organization services alongside pharmaceutical distribution and dispensing pharmacy operations. Overlaps with Toho in dispensing pharmacy and clinical trial support, though more concentrated in the clinical research value chain.
• Shanghai Pharmaceuticals Holding: One of China's largest vertically integrated pharmaceutical groups spanning manufacturing, distribution, and retail pharmacy. Comparable as an Asia-based integrated wholesale-pharmacy-manufacturing player, though operating in a different regulatory and reimbursement environment than Japan's.

Others

• Daiichi Sankyo Healthcare: OTC and consumer healthcare division of Daiichi Sankyo group, operating in self-medication and over-the-counter channels. Adjacent player to Toho's OTC business within the dispensing pharmacy segment, though positioned more in branded consumer healthcare.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/toho-holdings-co-ltd

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Toho Holdings